Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
2019-004054-28Phase 2Unknown
- Sponsor
- Imperial College London
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of psilocybin in anorexia nervosa (AN), sponsored by Imperial College London. Primary endpoint: Eating Disorder Examination interview and questionnaire. Status: unknown.
02
Drugs
psilocybin
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on 2019-004054-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004054-28.